{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T21:08:47Z","timestamp":1762808927504,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:00:00Z","timestamp":1587945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:00:00Z","timestamp":1587945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100008363","name":"Danish Cancer Society","doi-asserted-by":"crossref","award":["R163-A10654"],"award-info":[{"award-number":["R163-A10654"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s11606-020-05845-8","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T17:41:49Z","timestamp":1588009309000},"page":"2647-2654","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Human Papillomavirus Vaccination and Physical and Mental Health Complaints Among Female Students in Secondary Education Institutions in Denmark"],"prefix":"10.1007","volume":"35","author":[{"given":"Tatjana","family":"Gazibara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lau Caspar","family":"Thygesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Holst","family":"Algren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janne Schurmann","family":"Tolstrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,27]]},"reference":[{"key":"5845_CR1","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.vaccine.2011.11.097","volume":"30","author":"BB Sander","year":"2012","unstructured":"Sander BB, Rebolj M, Valentiner-Branth P, Lynge E. Introduction of human papillomavirus vaccination in Nordic countries. Vaccine. 2012; 30:1425-33.","journal-title":"Vaccine."},{"key":"5845_CR2","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1186\/s12889-018-6268-x","volume":"18","author":"CH Suppli","year":"2018","unstructured":"Suppli CH, Hansen ND, Rasmussen M, Valentiner-Branth P, Krause TG, M\u00f8lbak K. Decline in HPV-vaccination uptake in Denmark - the association between HPV-related media coverage and HPV-vaccination. BMC Public Health. 2018; 18:1360.","journal-title":"BMC Public Health."},{"key":"5845_CR3","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1016\/j.vaccine.2015.03.098","volume":"33","author":"LS Brinth","year":"2015","unstructured":"Brinth LS, Pors K, Theibel AC, Mehlsen J. Orthostatic intolerance and postural tachycardia syndrome as suspected adverse effects of vaccination against human papilloma virus. Vaccine. 2015; 33:2602-5.","journal-title":"Vaccine."},{"key":"5845_CR4","doi-asserted-by":"publisher","unstructured":"Hansen PR, Schmidtblaicher M, Brewer NT. Resilience of HPV vaccine uptake in Denmark: Decline and recovery. Vaccine. In press; https:\/\/doi.org\/10.1016\/j.vaccine.2019.12.019.","DOI":"10.1016\/j.vaccine.2019.12.019"},{"key":"5845_CR5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/joim.12694","volume":"283","author":"A Hviid","year":"2018","unstructured":"Hviid A, Svanstr\u00f6m H, Scheller NM, Gr\u00f6nlund O, Pasternak B, Arnheim-Dahlstr\u00f6m L. Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases. J Intern Med. 2018; 283:154-65.","journal-title":"J Intern Med."},{"key":"5845_CR6","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1016\/j.vaccine.2017.06.031","volume":"35","author":"B Feiring","year":"2017","unstructured":"Feiring B, Laake I, Bakken IJ, et al. HPV vaccination and risk of chronic fatigue syndrome\/myalgic encephalomyelitis: A nationwide register-based study from Norway. Vaccine. 2017; 35:4203-12.","journal-title":"Vaccine."},{"key":"5845_CR7","doi-asserted-by":"publisher","first-page":"5926","DOI":"10.1016\/j.vaccine.2018.06.074","volume":"36","author":"J Skufca","year":"2018","unstructured":"Skufca J, Ollgren J, Artama M, Ruokokoski E, Nohynek H, Palmu AA. The association of adverse events with bivalent human papilloma virus vaccination: A nationwide register-based cohort study in Finland. Vaccine. 2018; 36:5926-33.","journal-title":"Vaccine"},{"key":"5845_CR8","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1056\/NEJMoa1612296","volume":"376","author":"NM Scheller","year":"2017","unstructured":"Scheller NM, Pasternak B, M\u00f8lgaard-Nielsen D, Svanstr\u00f6m H, Hviid A. Quadrivalent HPV Vaccination and the Risk of Adverse Pregnancy Outcomes. N Engl J Med. 2017; 376:1223-33.","journal-title":"N Engl J Med."},{"key":"5845_CR9","unstructured":"World Health Organization (WHO). Global Vaccine Safety. Safety update on HPV vaccines. Available at https:\/\/www.who.int\/vaccine_safety\/committee\/topics\/hpv\/June_2017\/en\/ Accessed on Apr 1, 2019"},{"key":"5845_CR10","first-page":"e0162520","volume":"11","author":"K M\u00f8lbak","year":"2016","unstructured":"M\u00f8lbak K, Hansen ND, Valentiner-Branth P. Pre-vaccination care-seeking in females reporting severe adverse reactions to hpv vaccine. a registry based case-control study. PLoS One. 2016; 11:e0162520.","journal-title":"Pre-vaccination care-seeking in females reporting severe adverse reactions to hpv vaccine. a registry based case-control study. PLoS One."},{"key":"5845_CR11","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.vaccine.2019.02.029","volume":"37","author":"LW Krogsgaard","year":"2019","unstructured":"Krogsgaard LW, Bech BH, Plana-Ripoll O, Thomsen RW, Rytter D. Hospital contacts and diagnoses five years prior to HPV vaccination among females referred for suspected adverse vaccine effects: A Danish nationwide case-control study. Vaccine. 2019; 37:1763-8.","journal-title":"Vaccine."},{"issue":"7495","key":"5845_CR12","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1136\/bmj.330.7495.835","volume":"330","author":"PA Michaud","year":"2005","unstructured":"Michaud PA, Fombonne E. Common mental health problems. BMJ. 2005;330(7495):835-8.","journal-title":"BMJ."},{"issue":"7498","key":"5845_CR13","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1136\/bmj.330.7498.1012","volume":"330","author":"R Viner","year":"2005","unstructured":"Viner R, Christie D. Fatigue and somatic symptoms. BMJ. 2005;330(7498):1012-5.","journal-title":"BMJ."},{"key":"5845_CR14","doi-asserted-by":"publisher","unstructured":"Pisinger V, Mikkelsen SS, Bendtsen P, Egan KK, Tolstrup JS. The Danish National Youth Study 2014: Study design, population characteristics and non-response analysis. Scand J Public Health, in press https:\/\/doi.org\/10.1177\/1403494817729283","DOI":"10.1177\/1403494817729283"},{"key":"5845_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2807\/ese.17.17.20155-en","volume":"17","author":"T Grove Krause","year":"2012","unstructured":"Grove Krause T, Jakobsen S, Haarh M, M\u00f8lbak K. The Danish vaccination register. Euro Surveill. 2012; 17:1-6.","journal-title":"Euro Surveill."},{"key":"5845_CR16","unstructured":"European Union Agency for Fundamental Rights. Consent to use data on children. Available from https:\/\/fra.europa.eu\/en\/publication\/2017\/mapping-minimum-age-requirements\/use-consent. Accessed 17 Jan 2020."},{"key":"5845_CR17","unstructured":"Gordon M, Lumley T. Forestplot: Advanced Forest Plot Using 'grid' Graphics. Available from https:\/\/cran.r-project.org\/web\/packages\/forestplot\/index.html. Accessed 24 Sept 2019."},{"key":"5845_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1172\/JCI85446","volume":"126","author":"DR Lowy","year":"2016","unstructured":"Lowy DR. HPV vaccination to prevent cervical cancer and other HPV-associated disease: from basic science to effective interventions J Clin Invest. 2016; 126:5\u201311.","journal-title":"J Clin Invest."},{"key":"5845_CR19","doi-asserted-by":"publisher","first-page":"5416","DOI":"10.1016\/j.vaccine.2017.07.113","volume":"36","author":"PJ Maver","year":"2018","unstructured":"Maver PJ, Poljak M. Progress in prophylactic human papillomavirus (HPV) vaccination in 2016: A literature review. Vaccine. 2018; 36:5416-23.","journal-title":"Vaccine."},{"key":"5845_CR20","doi-asserted-by":"publisher","first-page":"e156","DOI":"10.1017\/S0950268818003679","volume":"147","author":"HA Garc\u00eda-Perdomo","year":"2019","unstructured":"Garc\u00eda-Perdomo HA, Osorio JC, Fernandez A, Zapata-Copete JA, Castillo A. The effectiveness of vaccination to prevent the papillomavirus infection: a systematic review and meta-analysis. Epidemiol Infect. 2019; 147:e156.","journal-title":"Epidemiol Infect."},{"key":"5845_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/cid\/cix797","volume":"66","author":"SK Kjaer","year":"2018","unstructured":"Kjaer SK, Nyg\u00e5rd M, Dillner J, et al. A 12-Year Follow-up on the Long-Term Effectiveness of the Quadrivalent Human Papillomavirus Vaccine in 4 Nordic Countries. Clin Infect Dis. 2018; 66:339-45.","journal-title":"Clin Infect Dis."},{"key":"5845_CR22","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1016\/j.vaccine.2013.06.064","volume":"31","author":"M Brisson","year":"2013","unstructured":"Brisson M, Laprise JF, Drolet M, et al. Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study. Vaccine. 2013; 31:3863-71.","journal-title":"Vaccine."},{"key":"5845_CR23","first-page":"1","volume":"64","author":"C Cramon","year":"2017","unstructured":"Cramon C, Poulsen CL, Hartling UB, Holden IK, Johansen IS. Possible adverse effects of the quadrivalent human papillomavirus vaccine in the Region of Southern Denmark: a retrospective, descriptive cohort study. Dan Med J. 2017; 64:1-6.","journal-title":"Dan Med J."},{"key":"5845_CR24","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s40264-017-0574-6","volume":"40","author":"K Ozawa","year":"2017","unstructured":"Ozawa K, Hineno A, Kinoshita T, Ishihara S, Ikeda SI. Suspected Adverse Effects After Human Papillomavirus Vaccination: A Temporal Relationship Between Vaccine Administration and the Appearance of Symptoms in Japan. Drug Saf. 2017; 40:1219-29.","journal-title":"Drug Saf."},{"key":"5845_CR25","first-page":"82","volume":"2","author":"H Beppu","year":"2017","unstructured":"Beppu H, Minaguchi M, Uchide K, Kumamoto K, Sekiguchi M, Yaju Y. Lessons learnt in Japan from adverse reactions to the HPV vaccine: a medical ethics perspective. Indian J Med Ethics. 2017; 2:82-8.","journal-title":"Indian J Med Ethics."},{"key":"5845_CR26","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.4161\/21645515.2014.969618","volume":"10","author":"HJ Larson","year":"2014","unstructured":"Larson HJ, Wilson R, Hanley S, Parys A, Paterson P. Tracking the global spread of vaccine sentiments: the global response to Japan's suspension of its HPV vaccine recommendation. Hum Vaccin Immunother. 2014; 10:2543-50.","journal-title":"Hum Vaccin Immunother."},{"key":"5845_CR27","doi-asserted-by":"publisher","first-page":"k3694","DOI":"10.1136\/bmj.k3694","volume":"362","author":"L J\u00f8rgensen","year":"2018","unstructured":"J\u00f8rgensen L, Doshi P, G\u00f8tzsche P, Jefferson T. Challenges of independent assessment of potential harms of HPV vaccines. BMJ. 2018; 362:k3694.","journal-title":"BMJ."},{"key":"5845_CR28","unstructured":"European Agency for the Evaluation of Medicinal Products (2002). Committee for Proprietary Medicinal Products. Points to consider on multiplicity issues in clinical trials. Available from https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/points-consider-multiplicity-issues-clinical-trials_en.pdf. Accessed 17 Jan 2020."},{"key":"5845_CR29","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1016\/j.vaccine.2016.02.040","volume":"34","author":"XC Liu","year":"2016","unstructured":"Liu XC, Bell CA, Simmonds KA, Svenson LW, Russell ML. Adverse events following HPV vaccination, Alberta 2006-2014. Vaccine. 2016; 34:1800-5.","journal-title":"Vaccine."},{"key":"5845_CR30","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.vaccine.2014.01.004","volume":"32","author":"T Harris","year":"2014","unstructured":"Harris T, Williams DM, Fediurek J, Scott T, Deeks SL. Adverse events following immunization in Ontario's female school-based HPV program. Vaccine. 2014; 32:1061-6.","journal-title":"Vaccine."},{"key":"5845_CR31","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/14740338.2019.1598969","volume":"18","author":"C Scavone","year":"2019","unstructured":"Scavone C, Di Mauro C, Brusco S, et al. Surveillance of adverse events following immunization related to human papillomavirus vaccines: 12 years of vaccinovigilance in Southern Italy. Expert Opin Drug Saf. 2019; 18:427-33.","journal-title":"Expert Opin Drug Saf."},{"key":"5845_CR32","doi-asserted-by":"publisher","first-page":"6796","DOI":"10.1016\/j.vaccine.2018.09.019","volume":"36","author":"TM Schurink-Van't Klooster","year":"2018","unstructured":"Schurink-Van't Klooster TM, Kemmeren JM, van der Maas NAT, et al. No evidence found for an increased risk of long-term fatigue following human papillomavirus vaccination of adolescent girls. Vaccine. 2018; 36:6796-802.","journal-title":"Vaccine."},{"key":"5845_CR33","doi-asserted-by":"publisher","first-page":"e0184658","DOI":"10.1371\/journal.pone.0184658","volume":"12","author":"LW Krogsgaard","year":"2017","unstructured":"Krogsgaard LW, Vestergaard CH, Plana-Ripoll O, et al. Health care utilization in general practice after HPV vaccination-A Danish nationwide register-based cohort study. PLoS One. 2017; 12:e0184658.","journal-title":"PLoS One."},{"key":"5845_CR34","doi-asserted-by":"publisher","first-page":"6158","DOI":"10.1016\/j.vaccine.2018.08.061","volume":"36","author":"S Ulendorf Jacobsen","year":"2018","unstructured":"Ulendorf Jacobsen S, Valentiner-Branth P, M\u00f8lbak K. Examining determinants for reporting suspected adverse events following HPV vaccination in Denmark. Vaccine. 2018; 36:6158-62.","journal-title":"Vaccine."},{"issue":"7 Suppl","key":"5845_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/1403494811401482","volume":"39","author":"E Lynge","year":"2011","unstructured":"Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011; 39(7 Suppl):30-3.","journal-title":"Scand J Public Health."},{"key":"5845_CR36","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1007\/s12026-018-9036-1","volume":"66","author":"S Blitshteyn","year":"2018","unstructured":"Blitshteyn S, Brinth L, Hendrickson JE, Martinez-Lavin M. Autonomic dysfunction and HPV immunization: an overview. Immunol Res. 2018; 66:744-54.","journal-title":"Immunol Res."},{"key":"5845_CR37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00018-018-2925-6","volume":"76","author":"J Campbell-Tofte","year":"2019","unstructured":"Campbell-Tofte J, Vrahatis A, Josefsen K, Mehlsen J, Winther K. Investigating the aetiology of adverse events following HPV vaccination with systems vaccinology. Cell Mol Life Sci. 2019; 76:67-87.","journal-title":"Cell Mol Life Sci."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-05845-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-020-05845-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-05845-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:28:35Z","timestamp":1619483315000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-020-05845-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,27]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["5845"],"URL":"https:\/\/doi.org\/10.1007\/s11606-020-05845-8","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"type":"print","value":"0884-8734"},{"type":"electronic","value":"1525-1497"}],"subject":[],"published":{"date-parts":[[2020,4,27]]},"assertion":[{"value":"29 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they do not have a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}